Clinical trial
Nijmegen Antihypertensive Management Improvement Study
NCT00457483 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00457483 |
|---|---|
| Title | Nijmegen Antihypertensive Management Improvement Study |
| Official title | A Cross-over Trial to Identify Patient Characteristics That Predict Blood Pressure Response to Antihypertensive Therapy in General Practice |
| Acronym | NAMIS |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Primary Hypertension |
| Intervention type | Drug |
| Interventions | hydrochlorothiazide, valsartan, 80 mg once-a-day |
| Enrollment | 120 |
| Start date | Aug 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Apr 6, 2007 |
| Last update posted | Feb 14, 2012 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: